Sickle Cell Disease
Mostrando 1-12 de 404 artigos, teses e dissertações.
-
1. É necessário encaminhar pacientes com traço falciforme ao hematologista?
Não é necessário encaminhar pacientes com traço falciforme ao hematologista.
Portadores de traço falciforme não possuem uma doença, mas uma característica genética que não requer tratamento.
Esse achado é detectado pela eletroforese de hemoglobina ou pelo Teste do Pezinho que identifica mutação de um alelo do gene da hemoglobina,
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Quais os cuidados devem ser tomados durante o tratamento odontológico de gestantes portadoras de anemia falciforme?
Gestação e anemia falciforme são duas condições especiais das quais o dentista precisa estar ciente para realizar com segurança o atendimento odontológico.
1. Estudos demonstram que o período mais seguro para tratamento em gestantes é durante o segundo trimestre de gestação
. A maioria dos tratamentos odontológicos pode ser reali
Núcleo de Telessaúde Espírito Santo. Publicado em: 12/06/2023
-
3. Bibliometric analysis of global sickle cell disease research from 1997 to 2017
Abstract Introduction Sickle cell disease is an autosomal recessive genetic disease caused by a single point mutation in the β-globin chain of the hemoglobin. It has been recognized by the World Health Organization as a public health priority since 2006. Methods The Scopus database was used in this study with the search descriptors: “sickle cell” and
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
4. Omega 3 fatty acids - Potential modulators for oxidative stress and inflammation in the management of sickle cell disease
Abstract Objective Sickle cell disease is characterized by clinical complications resulting in vaso-occlusive crisis with prominent attributes of oxidative stress, inflammation, and pain. Inflammation is an integral part of this disease which further exacerbates the pain during a crisis. Omega-3 fatty acids are known to possess anti-inflammatory and anti-ag
Jornal de Pediatria. Publicado em: 2022
-
5. Lipids and Sickle Cell Disease
International Journal of Cardiovascular Sciences. Publicado em: 2022
-
6. Bradycardia associated with antithymocyte globulin treatment of a pediatric patient with sickle cell disease: a case report and literature review
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
7. Guidelines on sickle cell disease: secondary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular guidelines project: Associação Médica Brasileira - 2022
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
8. Guidelines on sickle cell disease: primary stroke prevention in children and adolescents. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Guidelines project: Associação Médica Brasileira - 2021
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
9. Sickle cell disease related mortality in Brazil, 2000-2018
Abstract Introduction There is a demand to update national mortality trends data related to sickle cell disease (SCD) in Brazil. This study describes causes of death and mortality issues related to SCD using the multiple-cause-of-death methodology. Methods The annual SCD mortality data was extracted from the public databases of the Mortality Information Sy
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
10. Association Between Lipid Profile and Clinical Manifestations in Sickle Cell Anemia: A Systematic Review
Abstract Introduction Sickle cell anemia (SCA) is a genetic disease associated with frequent episodes of acute illness. Changes in the lipid profile and a chronic inflammatory process make up the molecular aspects observed in this disease. Associations between these mechanisms and clinical manifestations could thus define severity profiles and therapeutic
International Journal of Cardiovascular Sciences. Publicado em: 2022
-
11. Maternal and perinatal outcomes in pregnant women with sickle cell disease: an update
ABSTRACT Introduction: The aim of this study was to describe maternal and perinatal outcomes in pregnant women with sickle cell disease (SCD) followed at Santa Casa de Sao Paulo over a 10-year period (between 2010 and 2019). Method: Fifty-five records of pregnancies were analyzed among 35 women with SCD. Results: Among 29 newborns, 19 (65.5%) were full-te
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
12. HemoTypeSC point-of-care testing shows high sensitivity with alkaline cellulose acetate hemoglobin electrophoresis for screening hemoglobin SS and SC genotypes
ABSTRACT Introduction: By providing timely actionable results for prompt management, point-of-care testing (POCT) kits have revolutionised medical care for various diseases, ranging from infectious diseases like malaria to genetic disorders, such as sickle cell disease (SCD). They are, however, underutilised in the diagnosis of SCD in developing countries,
Hematology, Transfusion and Cell Therapy. Publicado em: 2022